LEANNA SCHEIDEMANTEL: Open Payments
NPI 1861158545 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,529 in 139 payments from 16 companies in 2025. Trend: 2023 $3,089 · 2024 $3,649 · 2025 $3,529
Food & beverage: $3,529
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $1,086 |
| UCB, Inc. | 23 | $658 |
| AstraZeneca Pharmaceuticals LP | 14 | $321 |
| Amgen Inc. | 16 | $261 |
| Lilly USA, LLC | 11 | $241 |
| Novartis Pharmaceuticals Corporation | 8 | $224 |
| Janssen Biotech, Inc. | 7 | $190 |
| PFIZER INC. | 7 | $116 |
| GENZYME CORPORATION | 3 | $114 |
| GlaxoSmithKline, LLC. | 5 | $94 |
Products named: RINVOQ, Bimzelx, SAPHNELO, TREMFYA, COSENTYX, SKYRIZI, TALTZ, XELJANZ.
Industry payments across MO — which companies pay providers there.
